ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Neoplasm Metastasis
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near Berlin, BE, DEU:

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 145 other locations

with HR-positive, HER2-negative locally advanced or metastatic breast cancer with gBRCA1/2 mutation, with 2:1 randomization into Ar...

Enrolling
Advanced or Metastatic Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
Drug: Olaparib + Elacestrant
Drug: Olaparib

Phase 2

GBG Forschungs GmbH

Berlin, State of Berlin, Germany and 35 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Berlin, Germany and 318 other locations

This is a single-arm, open-label phase IV study of patients with advanced HR+/HER2- breast cancer who are treated first line with r...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Ribociclib

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 51 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 80 other locations

treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.HR-positive breast cancer cells have...

Enrolling
Breast Cancer
Drug: Fulvestrant
Drug: Exemestane

Phase 3

Pfizer
Pfizer

Berlin, Germany and 205 other locations

elacestrant vs standard endocrine therapy in patients with ER+/HER2- breast cancer and ctDNA relapse.During the ctDNA screening pha...

Enrolling
ER-positive Breast Cancer
Stage IIB Breast Cancer
Drug: Exemestane 25 MG
Drug: Anastrozole 1mg

Phase 3

European Organisation for Research and Treatment of Cancer (EORTC)

Potsdam, Germany and 108 other locations

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Berlin, Germany and 260 other locations

The treatment of patients with HER2 positive early breast cancer has continuously improved over the last decades. Up to now both, t ...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Chemotherapy
Drug: Pertuzumab

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 10 other locations

has improved treatment prospects for patients with metastatic breast cancer whose tumour cells express hormone receptors but not th...

Enrolling
Breast Cancer
Other: De-escalation
Drug: Chemotherapy followed by endocrine therapy and ribociclib treatment

Phase 3

Unicancer
Unicancer

Berlin, Germany and 137 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems